文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

纽约医院强制性脓毒症方案化诊疗的经济学分析

Economic Analysis of Mandated Protocolized Sepsis Care in New York Hospitals.
PubMed 文献 · Crit Care Med · 2020-01-01
一句话结论纽约州2013年脓毒症强制规范未显著改变脓毒症住院患者的风险校正人均住院费用(p=0.12)或日均费用(p=0.44)。

该回顾性队列研究利用美国医疗成本与利用项目州出院数据,采用比较中断时间序列分析,纳入2011年1月1日至2015年9月30日纽约州及佛罗里达、马萨诸塞、马里兰、新泽西四个对照州共520家医院1,026,664例脓毒症住院患者。2013年纽约州强制要求所有医院制定并实施脓毒症识别与治疗方案、培训员工并向州报告绩效数据。结果显示,规范实施后纽约州风险校正人均住院费用与对照州相比差异无统计学意义(p=0.12),风险校正日均费用差异亦无统计学意义(p=0.44);实施后第10个季度纽约州风险校正人均费用较预期多3,627美元(95%CI -681至7,934)。作者结论为强制性方案化脓毒症诊疗与住院费用无显著变化相关。

要点

  • 纳入纽约州及四个对照州520家医院1,026,664例脓毒症住院患者,比较2013年纽约州脓毒症强制规范前后费用变化。
  • 纽约州未校正人均费用由规范前42,036±60,940美元降至规范后39,719±59,063美元,对照州由34,642±52,403美元降至31,414±48,155美元。
  • 比较中断时间序列显示,规范与风险校正人均住院费用差异无显著关联(p=0.12),与风险校正日均费用差异亦无显著关联(p=0.44)。
  • 实施后第10个季度,纽约州风险校正人均住院费用较预期多3,627美元(95%CI -681至7,934)。
  • 作者结论:强制性方案化脓毒症诊疗与脓毒症住院患者住院费用无显著变化相关。

适用人群与场景

  • 2011年1月1日至2015年9月30日期间在纽约州及佛罗里达、马萨诸塞、马里兰、新泽西四个对照州的综合、短期、急症照护医院住院的脓毒症患者。

处置流程与药物剂量

  • 2013年纽约州强制要求所有医院制定并实施脓毒症识别与治疗方案、培训员工并向州报告绩效数据。

研究设计与关键结果

  • 研究类型为回顾性队列研究,采用比较中断时间序列分析,数据来自美国医疗成本与利用项目州出院数据,费用由入院级收费数据按医院特异性成本收费比计算。
  • 共纳入520家医院1,026,664例脓毒症住院患者。
  • 纽约州未校正人均住院费用规范前为42,036±60,940美元,规范后为39,719±59,063美元;对照州规范前为34,642±52,403美元,规范后为31,414±48,155美元。
  • 比较中断时间序列分析中,规范与风险校正人均住院费用差异无显著关联(p=0.12),与风险校正日均费用差异亦无显著关联(p=0.44)。
  • 实施后第10个季度,纽约州风险校正人均住院费用较对照州预期多3,627美元(95%CI -681至7,934)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论为强制性方案化脓毒症诊疗与脓毒症住院患者住院费用无显著变化相关,原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Initial evidence suggests that state-level regulatory mandates for sepsis quality improvement are associated with decreased sepsis mortality. However, sepsis mandates require financial investments on the part of hospitals and may lead to increased spending. We evaluated the effects of the 2013 New York State sepsis regulations on the costs of care for patients hospitalized with sepsis.

DESIGN: Retrospective cohort study using state discharge data from the U.S. Healthcare Costs and Utilization Project and a comparative interrupted time series analytic approach. Costs were calculated from admission-level charge data using hospital-specific cost-to-charge ratios.

SETTING: General, short stay, acute care hospitals in New York, and four control states: Florida, Massachusetts, Maryland, and New Jersey.

PATIENTS: All patients hospitalized with sepsis between January 1, 2011, and September 30, 2015.

INTERVENTIONS: The 2013 New York mandate that all hospitals develop and implement protocols for sepsis identification and treatment, educate staff, and report performance data to the state.

MEASUREMENTS AND MAIN RESULTS: The analysis included 1,026,664 admissions in 520 hospitals. Mean unadjusted costs per hospitalization in New York State were $42,036 ± $60,940 in the pre-regulation period and $39,719 ± $59,063 in the post-regulation period, compared with $34,642 ± $52,403 pre-regulation and $31,414 ± $48,155 post-regulation in control states. In the comparative interrupted time series analysis, the regulations were not associated with a significant difference in risk-adjusted mean cost per hospitalization (p = 0.12) or risk-adjusted mean cost per hospital day (p = 0.44). For example, in the 10th quarter after implementation of the regulations, risk-adjusted mean cost per hospitalization was $3,627 (95% CI, -$681 to $7,934) more than expected in New York State relative to control states.

CONCLUSIONS: Mandated protocolized sepsis care was not associated with significant changes in hospital costs in patients hospitalized with sepsis in New York State.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Bourne DS, Davis BS, Gigli KH, et al. Economic Analysis of Mandated Protocolized Sepsis Care in New York Hospitals. Crit Care Med. 2020. PMID: 32931187. doi:10.1097/CCM.0000000000004514

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。